Litcius/Paper detail

Potently neutralizing and protective human antibodies against SARS-CoV-2

Seth J. Zost, Pavlo Gilchuk, James Brett Case, Elad Binshtein, Rita E. Chen, Joseph P. Nkolola, Alexandra Schäfer, Joseph X. Reidy, Andrew Trivette, Rachel S. Nargi, Rachel E. Sutton, Naveenchandra Suryadevara, David R. Martinez, Lauren E. Williamson, Elaine C. Chen, Taylor Jones, Samuel B. Day, Luke Myers, Ahmed O. Hassan, Natasha M. Kafai, Emma S. Winkler, Julie M. Fox, Swathi Shrihari, Benjamin K. Mueller, Jens Meiler, Abishek Chandrashekar, Noe B. Mercado, James J. Steinhardt, Kuishu Ren, Yueh–Ming Loo, Nicole L. Kallewaard, Broc T. McCune, Shamus P. Keeler, Michael J. Holtzman, Dan H. Barouch, Lisa E. Gralinski, Ralph S. Baric, Larissa B. Thackray, Michael Diamond, Robert H. Carnahan, James E. Crowe

2020Nature1,194 citationsDOIOpen Access PDF

Topics & Concepts

Monoclonal antibodyEpitopeAntibodyVirologyNeutralizing antibodyImmunologyMedicineBiologySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesViral Infections and Immunology Research
Potently neutralizing and protective human antibodies against SARS-CoV-2 | Litcius